Search research articles
Contact Us
Filters
Showing results (211-220 of 352) with videos related to
Page
of 36
Sort By:
The Lancet. Oncology
|
August 12, 2016
Novel therapeutic targets on the horizon for lung cancer
Wan-Ling Tan, Amit Jain, Angela Takano, et al.
Cell Death & Disease
|
June 27, 2014
Validation of a chloroquine-induced cell death mechanism for clinical use against malaria
J-H Ch'ng, Y-Q Lee, S Y Gun, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
September 21, 2025
TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non-small cell lung cancer
David R Jones, Isabelle Opitz, David Harpole, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2013
Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors
L Rhoda Molife, Sarah M Rudman, Salma Alam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with <i>BRAF</i> -mutant Solid Tumors
Ryan J Sullivan, Jeffrey Weber, Sapna Patel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 23, 2023
Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 study
Jürgen Wolf, Edward B Garon, Harry J M Groen, et al.
Msphere
|
January 24, 2018
Targeted Phenotypic Screening in <i>Plasmodium falciparum</i> and <i>Toxoplasma gondii</i> Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules
Gowtham Subramanian, Meenakshi A Belekar, Anurag Shukla, et al.
ESMO Open
|
July 22, 2022
Trials without borders-decentralized trials and ensuring access to novel cancer therapies during a global pandemic
A C Tan, T J Y Tan, S P L Saw, et al.
Msphere
|
March 15, 2019
Erratum for Subramanian et al., "Targeted Phenotypic Screening in <i>Plasmodium falciparum</i> and <i>Toxoplasma gondii</i> Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules"
Gowtham Subramanian, Meenakshi A Belekar, Anurag Shukla, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2007
Effect of plasmodial RESA protein on deformability of human red blood cells harboring Plasmodium falciparum
J P Mills, M Diez-Silva, D J Quinn, et al.
Page
of 36
Search research articles
Search
Showing results (211-220 of 352) with videos related to
Sort By:
Page
of 36
The Lancet. Oncology
|
August 12, 2016
Novel therapeutic targets on the horizon for lung cancer
Wan-Ling Tan, Amit Jain, Angela Takano, et al.
Cell Death & Disease
|
June 27, 2014
Validation of a chloroquine-induced cell death mechanism for clinical use against malaria
J-H Ch'ng, Y-Q Lee, S Y Gun, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
September 21, 2025
TROPION-Lung12: A phase 3 study of adjuvant datopotamab deruxtecan and rilvegostomig in ctDNA-positive or high-risk pathology stage I non-small cell lung cancer
David R Jones, Isabelle Opitz, David Harpole, et al.
Cancer Chemotherapy and Pharmacology
|
October 3, 2013
Phase II, open-label trial to assess QTcF effects, pharmacokinetics and antitumor activity of afatinib in patients with relapsed or refractory solid tumors
L Rhoda Molife, Sarah M Rudman, Salma Alam, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 17, 2020
A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with <i>BRAF</i> -mutant Solid Tumors
Ryan J Sullivan, Jeffrey Weber, Sapna Patel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 23, 2023
Patient-reported outcomes in capmatinib-treated patients with METex14-mutated advanced NSCLC: Results from the GEOMETRY mono-1 study
Jürgen Wolf, Edward B Garon, Harry J M Groen, et al.
Msphere
|
January 24, 2018
Targeted Phenotypic Screening in <i>Plasmodium falciparum</i> and <i>Toxoplasma gondii</i> Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules
Gowtham Subramanian, Meenakshi A Belekar, Anurag Shukla, et al.
ESMO Open
|
July 22, 2022
Trials without borders-decentralized trials and ensuring access to novel cancer therapies during a global pandemic
A C Tan, T J Y Tan, S P L Saw, et al.
Msphere
|
March 15, 2019
Erratum for Subramanian et al., "Targeted Phenotypic Screening in <i>Plasmodium falciparum</i> and <i>Toxoplasma gondii</i> Reveals Novel Modes of Action of Medicines for Malaria Venture Malaria Box Molecules"
Gowtham Subramanian, Meenakshi A Belekar, Anurag Shukla, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 23, 2007
Effect of plasmodial RESA protein on deformability of human red blood cells harboring Plasmodium falciparum
J P Mills, M Diez-Silva, D J Quinn, et al.
Page
of 36